WBB Securities’ Stephen Brozak to Moderate Panel at 2012 BIO CEO and Investor Conference

PDF: 2.11.2012 WBB Securities’ Stephen Brozak to Moderate Panel at 2012 BIO CEO and Investor Conference

WBB Securities’ Stephen Brozak to Moderate Panel at 2012 BIO CEO and Investor Conference

Mr. Brozak to be joined by distinguished panel of venture investors and leading diagnostic companies

For Immediate Release
February 11, 2012

SAN DIEGO, CAWBB Securities Managing Partner and President, Stephen G. Brozak, will be moderating the Diagnostics workshop at the 2012 BIO CEO and Investor Conference. Mr. Brozak’s workshop will begin on February 14, 2012, at 10:30 am at the Waldorf-Astoria Hotel in New York, NY.

About WBB Securities

WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, California, WBB Securities is a registered independent broker dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the US serving institutional and high net worth clients.  The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  www.wbbsec.com

About BIO CEO & Investor Conference

Now in its fourteenth year, the BIO CEO & Investor Conference is the largest independent investor conference focused on publicly traded biotechnology companies.

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

The therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, dealmaking and investment trends on our business roundtables.